Showing results (91-100 of 268) with videos related to
Sort By:
Pageof 27
Postgraduate Medical Journal|March 14, 1998
Neuroleptic malignant syndrome in the acquired immunodeficiency syndromeJ L Hernández, L Palacios-Araus, S Echevarría, et al.Boletin Medico Del Hospital Infantil De Mexico|January 1, 1979
[Disseminated intravascular coagulation in children under 1 year of age]M E de Aquino Jaso, J Portilla Aguilar, H Guiscafré Gallardo, et al.Allergologia Et Immunopathologia|May 1, 1987
Intestinal and peripheral blood lymphocyte subpopulations in Crohn's diseaseJ Cagigas, S Echevarría, F Casafont, et al.Journal of Medical Virology|February 15, 2001
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitorsM Pérez-Olmeda, J Del Romero, A Rubio, et al.Journal of Internal Medicine|April 1, 1993
Renal failure due to sulphadiazine in AIDS patients with cerebral toxoplasmosisM C Fariñas, S Echevarría, I Sampedro, et al.Revista Espanola De Enfermedades Digestivas|August 1, 1990
[Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease]J L Lozano Polo, S Echevarría Vierna, F Casafont Morencos, et al.AIDS (London, England)|October 2, 2001
Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loadsA Tuldrà, C R Fumaz, M J Ferrer, et al.Epidemiology and Infection|October 31, 2002
Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug usersJ M Egea, R Muga, G Sirera, et al.HIV Medicine|November 21, 2008
Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patientsP Ryan, F Blanco, P García-Gascó, et al.Antiviral Therapy|May 7, 2003
Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimensM Pèrez-Olmeda, A Rubio, T Puig, et al.Pageof 27